Home > Products > HER2 & VEGF
> Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (sdAb-IgG)
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (sdAb-IgG) (CAT#: BSSG-405)
Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (sdAb-IgG) is formed by an IgG and two single domains antibodies (sdAbs). The sdAbs from an anti-VEGF antibody variable domain are respectively connected to the N terminus of the anti-HER2 IgG heavy chains or light chains to form sdAb-(H)IgG or sdAb-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can bind two factors simultaneously and inhibit cell proliferation. It is designed for the research of Colorectal cancer; Breast cancer; Lung cancer; Renal cell cancer (RCC); Glioma cancer; Glioblastoma; Ovarian cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-HER2 x Anti-VEGF Bispecific Antibody (sdAb-IgG) (BSSG-405). Click the button below to contact us or submit your feedback about this product.